Human Milk Fortifier Market Scope And Analysis

  • Report Code : TIPRE00017865
  • Category : Food and Beverages
  • Status : Published
  • No. of Pages : 122
Buy Now

Human Milk Fortifier Market Scope, Growth, Size and Share by 2030

Buy Now


Human Milk Fortifier Market Report Scope

Report Attribute Details
Market size in 2022 US$ 274.67 Million
Market Size by 2030 US$ 566.35 Million
Global CAGR (2022 - 2030) 9.6%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Form
  • Powder and Liquid
By Distribution Channel
  • Online and Offline
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • NeoLacta Lifesciences Pvt Ltd
  • Nestle SA
  • Prolacta Bioscience Inc
  • Lead Care International Ltd
  • Raptakos Brett Co Ltd
  • NeoKare Nutrition Ltd
  • Danone SA
  • Neolac Inc
  • Industry Developments and Future Opportunities:

    Various initiatives taken by the key players operating in the human milk fortifier market are listed below:

    • In January 2022, Prolacta Bioscience introduced human milk fortifiers in Japan. The launch was aimed at entering the untapped market in the country and helping improve the health of newborns. In November 2020, Lifeblood Milk and the South Australian Health and Medical Research Institute (SAHMRI) entered into collaboration with CSIRO, Australia's national science agency. The partnership aimed to develop human milk fortifiers to improve nutrition and growth in preterm babies.
    • In September 2021, Neolacta Lifesciences Pvt. Ltd launched its products on e-commerce platforms to ensure easy availability of its products such as Neolacta Human Breast Milk and Neolacta MMF (Mother's Milk Fortifier) to parents.

    Covid-19 Impact: 

    The COVID-19 pandemic initially affected the global human milk fortifier market due to the shutdown of manufacturing units, shortage of labor, disruption of supply chains, and financial instability. The disruption of various industries due to the economic slowdown caused by the COVID-19 outbreak restrained the demand for human milk fortifiers. However, businesses are gaining ground as previously imposed limitations have been eased across various countries. Moreover, the introduction of COVID-19 vaccines by governments of different countries eased the situation, leading to a rise in business activities worldwide. Several markets, including the human milk fortifier market, witnessed growth after the ease of lockdowns and movement restrictions.

    Competitive Landscape and Key Companies:

    Some of the prominent players operating in the global human milk fortifier market include Abbott Laboratories, NeoLacta Lifesciences Pvt Ltd, Nestle SA, Prolacta Bioscience Inc, Lead Care International Ltd, Raptakos, Brett & Co Ltd, NeoKare Nutrition Ltd, Danone SA, Neolac Inc, and Reckitt Benckiser Group Plc.